AI Cures Dog's Cancer Miracle

🔑 Enhanced Key Takeaways

• •Paul Conyngham, a Sydney-based AI consultant, initiated the project in November 2024 after conventional chemotherapy and surgery failed to shrink Rosie's mast cell tumors.[1][3]
• •Grok AI was used for the final mRNA vaccine design, in addition to ChatGPT and AlphaFold, and Conyngham employed his own custom machine learning algorithms for neoantigen selection.[3][7]
• •The treatment cost an estimated $20,000 to $50,000, including $3,000 AUD for DNA sequencing, with human experts like Professor Páll Thordarson building the actual vaccine at UNSW RNA Institute.[3][7]
• •Experts including biotech co-founder Egan Peltan criticize the hype, noting concurrent conventional immunotherapy likely contributed and that AI's role was assistive rather than essential.[3]
• •The story gained prominence after being shared by OpenAI President Greg Brockman and DeepMind CEO Demis Hassabis, fueling viral spread despite clarifications that it is not a cure.[3]

🛠️ Technical Deep Dive

• •DNA sequencing compared healthy cells to tumor cells to identify mutations, costing $3,000 AUD, followed by AlphaFold for 3D protein structure modeling of mutated proteins.[7]
• •Custom machine learning algorithms selected neoantigens—mutated proteins likely to trigger immune response—for targeting.[7]
• •Professor Páll Thordarson at UNSW RNA Institute synthesized the mRNA vaccine from Conyngham's half-page formula, administered with a booster shot.[7]
• •Computational pipelines detected cancer-driving mutations in the 320G gene sequencing data.[4]

🔮 Future ImplicationsAI analysis grounded in cited sources

⏳ Timeline